Grasso A A, Millia C C, Rampello L, Reggio A, De Simone D, Bousquet E, Rapisarda E
Boll Soc Ital Biol Sper. 1983 Jan 31;59(1):58-64.
It has long been shown by Biggio and Guidotti that multisynaptic nigro-cerebellar pathway of dopaminergic origin can control cerebellar cyclic guanosinmonophosphate (cGMP) content, a good index of the activity of Purkinje cells. In this line, it has been reported that haloperidol and sulpiride, significantly decrease cerebellar cGMP content while opposite changes are observed with apomorphine. In an attempt to establish whether other cerebellar cGMP-related parameters may be influenced by dopamine drugs. Authors have investigated the effects of haloperidol, sulpiride and apomorphine on cerebellar PGE2 and PGF2alpha. Results obtained indicate that haloperidol and sulpiride significantly reduce cerebellar PGE2 and PGF2alpha content while opposite changes are induced by apomorphine. Similar results have been observed in substantia nigra but not in other brain regions, such as corpus striatum and medial basal hypothalamus. The possibility that the observed changes in cerebellar PG-content may result from the modulation of striatal dopamine receptors is discussed.
比焦和吉多蒂早就指出,多巴胺能起源的多突触黑质 - 小脑通路可以控制小脑环磷酸鸟苷(cGMP)含量,这是浦肯野细胞活性的一个良好指标。按照这一思路,有报道称氟哌啶醇和舒必利会显著降低小脑cGMP含量,而阿扑吗啡则会产生相反的变化。为了确定其他与小脑cGMP相关的参数是否会受到多巴胺药物的影响,作者研究了氟哌啶醇、舒必利和阿扑吗啡对小脑前列腺素E2(PGE2)和前列腺素F2α(PGF2α)的影响。所得结果表明,氟哌啶醇和舒必利会显著降低小脑PGE2和PGF2α含量,而阿扑吗啡则会引发相反的变化。在黑质中观察到了类似结果,但在纹状体和内侧基底下丘脑等其他脑区未观察到。文中讨论了小脑PG含量的观察变化可能是由纹状体多巴胺受体调节引起的可能性。